GenMark Diagnostics Debt to Equity Ratio 2010-2019 | GNMK

Current and historical debt to equity ratio values for GenMark Diagnostics (GNMK) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. GenMark Diagnostics debt/equity for the three months ending March 31, 2019 was 1.96.
GenMark Diagnostics Debt/Equity Ratio Historical Data
Date Long Term Debt Shareholder's Equity Debt to Equity Ratio
2019-03-31 $0.05B $0.02B 1.96
2018-12-31 $0.04B $0.03B 1.07
2018-09-30 $0.03B $0.04B 0.69
2018-06-30 $0.01B $0.05B 0.19
2018-03-31 $0.02B $0.06B 0.24
2017-12-31 $0.02B $0.07B 0.28
2017-09-30 $0.01B $0.08B 0.12
2017-06-30 $0.02B $0.09B 0.16
2017-03-31 $0.01B $0.03B 0.45
2016-12-31 $0.01B $0.04B 0.31
2016-09-30 $0.01B $0.05B 0.30
2016-06-30 $0.02B $0.03B 0.59
2016-03-31 $0.01B $0.04B 0.25
2015-12-31 $0.01B $0.05B 0.20
2015-09-30 $0.01B $0.05B 0.18
2015-06-30 $0.01B $0.06B 0.15
2015-03-31 $0.01B $0.07B 0.13
2014-12-31 $0.00B $0.08B 0.00
2014-09-30 $0.00B $0.09B 0.00
2014-06-30 $0.00B $0.09B 0.00
2014-03-31 $0.00B $0.10B 0.00
2013-12-31 $0.00B $0.11B 0.00
2013-09-30 $0.00B $0.12B 0.00
2013-06-30 $0.00B $0.05B 0.00
2013-03-31 $0.00B $0.05B 0.00
2012-12-31 $0.00B $0.06B 0.00
2012-09-30 $0.00B $0.06B 0.00
2012-06-30 $0.00B $0.07B 0.00
2012-03-31 $0.00B $0.03B 0.02
2011-12-31 $0.00B $0.03B 0.02
2011-09-30 $0.00B $0.04B 0.02
2011-06-30 $0.00B $0.04B 0.03
2011-03-31 $0.00B $0.02B 0.13
2010-12-31 $0.00B $0.02B 0.00
2010-09-30 $0.00B $0.02B 0.00
2010-06-30 $0.00B $0.03B 0.00
2010-03-31 $0.00B 0.00
2009-12-31 $0.00B 0.00
2009-09-30 $0.00B 0.00
2009-06-30 $0.00B 0.00
2009-03-31 $0.00B 0.00
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $0.351B $0.071B
GenMark Diagnostics, Inc. is a molecular diagnostics company focused on developing and commercializing its proprietary eSensor(R) detection technology. The eSensor? XT-8 system is the second generation in GenMark Dx's eSensor? platform, utilizing electrochemical detection technology to detect nucleic acids on a microarray. The XT-8 System enables multiplex detection of DNA and RNA targets. The Company has developed four diagnostic tests for use with its XT-8 System. Its Cystic Fibrosis Genotyping Test, which detects pre-conception risks of cystic fibrosis, and its Warfarin Sensitivity Test, which determines an individual's ability to metabolize the oral anticoagulant warfarin, have received FDA clearance. It has also developed a Respiratory Viral Panel Test, which detects the presence of major respiratory viruses, and a Thrombosis Risk Test, which detects an individual's increased risk of blood clots. GenMark Diagnostics, Inc. is based in Pasadena, California.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $115.922B 25.36
Intuitive Surgical (ISRG) United States $61.051B 53.31
Edwards Lifesciences (EW) United States $40.518B 40.49
IDEXX Laboratories (IDXX) United States $24.496B 64.26
Fresenius Medical Care AG KGaA (FMS) Germany $23.093B 15.17
Teleflex (TFX) United States $15.464B 33.50
Olympus (OCPNY) Japan $15.120B 113.13
SONOVA HOLDING (SONVY) Switzerland $14.591B 0.00
Sysmex ADR (SSMXY) Japan $14.533B 39.18
DexCom (DXCM) United States $13.892B 272.46
Hologic (HOLX) United States $12.939B 20.81
STERIS (STE) Ireland $12.366B 29.91
Varian Medical Systems (VAR) United States $12.078B 30.81
ABIOMED (ABMD) United States $11.795B 71.75
Masimo (MASI) United States $8.182B 50.13
Penumbra (PEN) United States $6.119B 259.03
SARTORIUS AG (SARTF) Germany $5.850B 51.98
Elekta AB (EKTAY) Sweden $5.087B 38.33
Integra LifeSciences Holdings (IART) United States $4.653B 21.86
Globus Medical (GMED) United States $4.220B 26.31
Tandem Diabetes Care (TNDM) United States $3.752B 0.00
LivaNova (LIVN) United Kingdom $3.543B 23.09
Wright Medical Group (WMGI) Netherlands $3.423B 678.50
Cantel Medical (CMD) United States $3.306B 33.54
Glaukos (GKOS) United States $2.735B 0.00
Integer Holdings (ITGR) United States $2.652B 19.54
Nihon Kohden (NHNKY) Japan $2.401B 24.16
AVANOS MEDICAL, INC (AVNS) United States $1.903B 30.11
Nevro (NVRO) United States $1.882B 0.00
Inogen (INGN) United States $1.287B 28.48
Silk Road Medical (SILK) United States $1.279B 0.00
OPKO Health (OPK) United States $1.274B 0.00
Veracyte (VCYT) United States $1.243B 0.00
CryoLife (CRY) United States $1.123B 111.37
Accelerate Diagnostics (AXDX) United States $1.017B 0.00
Tactile Systems Technology (TCMD) United States $1.009B 148.86
ORTHOFIX MEDICAL INC (OFIX) United States $0.963B 27.90
ViewRay (VRAY) United States $0.915B 0.00
Luminex (LMNX) United States $0.897B 117.35
Natus Medical (BABY) United States $0.893B 20.67
Mesa Laboratories (MLAB) United States $0.878B 41.29
Pacific Biosciences Of California (PACB) United States $0.814B 0.00
Fluidigm (FLDM) United States $0.793B 0.00
AngioDynamics (ANGO) United States $0.789B 25.84
AxoGen (AXGN) United States $0.756B 0.00
Quotient (QTNT) Switzerland $0.692B 0.00
Intersect ENT (XENT) United States $0.641B 0.00
Corindus Vascular Robotics (CVRS) United States $0.552B 0.00
OrthoPediatrics (KIDS) United States $0.511B 0.00
Si-Bone (SIBN) United States $0.485B 0.00
Accuray (ARAY) United States $0.350B 0.00
Oxford Immunotec Global (OXFD) United Kingdom $0.350B 18.76
Semler Scientific (SMLR) United States $0.312B 61.99
RTI Surgical (RTIX) United States $0.303B 37.27
TransEnterix (TRXC) United States $0.302B 0.00
SeaSpine Holdings (SPNE) United States $0.241B 0.00
Neuronetics (STIM) United States $0.228B 0.00
Alphatec Holdings (ATEC) United States $0.210B 0.00
ConforMIS (CFMS) United States $0.209B 0.00
IRadimed (IRMD) United States $0.204B 38.89
CRH Medical (CRHM) Canada $0.198B 68.50
Sientra (SIEN) United States $0.172B 0.00
Stereotaxis (STXS) United States $0.166B 0.00
Second Sight Medical Products (EYES) United States $0.112B 0.00
Ekso Bionics Holdings (EKSO) United States $0.090B 0.00
Sensus Healthcare (SRTS) United States $0.087B 0.00
Vermillion (VRML) United States $0.075B 0.00
EDAP TMS S.A (EDAP) France $0.075B 0.00
T2 Biosystems (TTOO) United States $0.073B 0.00
Covalon Technologies (CVALF) Canada $0.071B 0.00
Apollo Endosurgery (APEN) United States $0.066B 0.00
Spectral Diagnostics (EDTXF) Canada $0.064B 0.00
Helius Medical Technologies (HSDT) United States $0.055B 0.00